LionexDiagnostics & Therapeutics GmbH Company Profile

04:28 EDT 19th March 2018 | BioPortfolio

Lionex is a biotech company dedicated to modern biomedicine for human health. Considering the revolutionary pace at which human and microbial genomic sequence information is progressing, it is becoming clear that rapid progress will also be made in future in identifying and developing new targets and drugs for the treatment of various infectious and non-infectious human diseases. Lionex is developing protein-focused technologies to enable the accelerated identification, development and production of new and improved products for combating major diseases, e.g. tuberculosis, heart diseases and cancer.


Mascheroder Weg 1b


Phone: 0049-531-260-12-66
Fax: 0049-531-260-11-59

News Articles [887 Associated News Articles listed on BioPortfolio]

Flexion Therapeutics to acquire novel and non-opioid asset for osteoarthritis of knee

Flexion Therapeutics has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203.

MiNA Therapeutics partners with BI for liver diseases

Sosei Group Corp.'s strategic minority investment company MiNA Therapeutics Ltd. agreed to partner with Boehringer Ingelheim GMBH to develop treatments for fibrotic liver diseases, including NASH.

Zum Tag der Seltenen Erkrankungen (Rare Disease Day 2018) erinnert PTC Therapeutics an das 150-jährige Jubiläum der ersten offiziellen Beschreibung der Duchenne-Muskeldystrophie (DMD)

Frankfurt am Main (ots) - PTC Therapeutics Germany GmbH unterstützt den Tag der Seltenen Erkrankungen 2018 (28. Februar) und gedenkt in diesem Zusammenhang des 150. Jahrestages, an dem die Symptome.....

Medigene-Aktie: Celgene bietet für JUNO Therapeutics über USD 9 Mrd.- Führungsprojekt vor Klinikstart

Frankfurt am Main - Medigene-Aktienanalyse von der EQUI.TS GmbH: Nach Analyse des Übernahmeangebots durch Celgene Corp. für Medigene's Mitbewerber JUNO Therapeutics bekräftigen Thomas J. Schießle ...

Dicerna partners with BI to develop hepatic therapeutics

Boehringer Ingelheim GMBH entered into a license agreement with Dicerna Pharmaceuticals Inc. in which the companies will use Dicerna's GalXC RNAi technology to develop therapeutics that target a speci...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

PubMed Articles [417 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Introduction to Volume 2 of JOPT Special Issue.

Introduction to Volume 1 of JOPT Special Issue.

Clinical Trials [175 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Companies [1718 Associated Companies listed on BioPortfolio]

LionexDiagnostics & Therapeutics GmbH

Lionex is a biotech company dedicated to modern biomedicine for human health. Considering the revolutionary pace at which human and microbial genomic sequence information is progressing, it is becomin...

SCT Spinal Cord Therapeutics GmbH

SCT Spinal Cord Therapeutics GmbH stands for pioneering the therapy of acute and chronic Spinal Cord Injuries (SCI) with its proprietary technology platform: the Regeneration Promoting Treatment (RPT)...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Isarna Therapeutics GmbH

Isarna Therapeutics has an unmatched commitment to developing TGF-β inhibitors that stimulate the human immune system to effectively fight cancer. Isarna Therapeutics are advancing a unique pip...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "LionexDiagnostics & Therapeutics GmbH" on BioPortfolio

We have published hundreds of LionexDiagnostics & Therapeutics GmbH news stories on BioPortfolio along with dozens of LionexDiagnostics & Therapeutics GmbH Clinical Trials and PubMed Articles about LionexDiagnostics & Therapeutics GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LionexDiagnostics & Therapeutics GmbH Companies in our database. You can also find out about relevant LionexDiagnostics & Therapeutics GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record